The changing epidemiology of adult liver transplantation in the United States in 2013-2022: the dominance of metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease
BMC Syst Biol 3:2
To report SUSPECTED ADVERSE EVENTS, contact Actavis at 1-800-272-5525 or FDA at 1-800-FDA-1088 or for voluntary reporting of adverse reactions
10.1038/s41380-025-02998-y
Our team of drug injury attorneys and class action lawyers is investigating potential GLP-1 gastroparesis lawsuit cases and settlement claims of individuals who were diagnosed with stomach paralysis or gastroparesis after using Ozempic, Mounjaro, Wegovy, Rybelsus, Trulicity, Zepbound, Saxenda or other GLP-1 agonist medications
The process for getting GLP-1s is clearly explained and guided by a physician, who will only prescribe GLP-1s if they feel the medication is suitable for your situation